Stocks · Korea
185750
KOSPI
Chong Kun Dang Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER11.25x
PBR0.87x
EPS5,882 KRW
BPS76,180 KRW
ROE7.64%
Dividend yield0.76%
DPS500 KRW
Payout ratio8.50%
Returns and 52-week range
1W+2.95%
1M-2.93%
3M-4.06%
6M-27.25%
1Y-20.24%
YTD-20.05%
52W high98,100원
52W low63,000원
From 52W high-32.52%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1.5조 | 1,099억 | 800억 | 7.4% |
| 2023 | 1.7조 | 2,466억 | 2,136억 | 14.8% |
| 2024 | 1.6조 | 995억 | 1,114억 | 6.3% |
| 2025 | 1.7조 | 806억 | 778억 | 4.8% |
| Quarterly | ||||
| 2024 4Q | 4,154억 | 68억 | 81억 | 1.6% |
| 2025 1Q | 4,010억 | 125억 | 119억 | 3.1% |
| 2025 2Q | 4,348억 | 236억 | 194억 | 5.4% |
| 2025 3Q | 4,298억 | 210억 | 202억 | 4.9% |
| 2025 4Q | 4,268억 | 235억 | 263억 | 5.5% |
| 2026 1Q | 4,478억 | 141억 | 126억 | 3.1% |
Company
Address: 서울 서대문구 충정로3가 3가 368 종근당빌딩
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-03-18사업보고서 (2025.12)
- 2025-11-14분기보고서 (2025.09)
- 2025-09-30주요사항보고서(자기주식처분결정) Major
- 2025-09-30주요사항보고서(교환사채권발행결정) Major
- 2025-08-14반기보고서 (2025.06)
- 2025-05-15분기보고서 (2025.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.